| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5660406 | Journal of Hepatology | 2017 | 13 Pages | 
Abstract
												The main trigger for liver injury in acquired cholestatic liver disease remains unclear. However, the accumulation of bile acids (BAs) undoubtedly plays a role. Recent progress in deciphering the pathomechanisms of inborn cholestatic liver diseases, decoding mechanisms of BA-induced cell death, and generating modern BA-derived drugs has improved the understanding of the regulation of BA synthesis and transport. Now is the appropriate time to reassess current knowledge about the specific role of BAs in hepatobiliary injury.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Gastroenterology
												
											Authors
												Peter Fickert, Martin Wagner, 
											